ASS1 and breast carcinoma: In breast cancer specifically, high ASS1 levels are associated with decreased survival [8], while ASS1 loss increases responsiveness to immune checkpoint blockade by reallocating aspartate toward pyrimidine synthesis and increasing mutational burden [9].